Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
medmix AG ( (CH:MEDX) ) has issued an update.
medmix Group has bolstered its presence in key global beauty markets by expanding its facilities in China and Brazil. The new production facility in China and the expanded operations in Brazil are expected to significantly enhance production capacity and drive revenue growth in the Asian and Latin American beauty markets. These expansions are part of medmix’s broader strategy to strengthen its market position and meet evolving customer needs through innovation and sustainable production processes.
The most recent analyst rating on (CH:MEDX) stock is a Hold with a CHF11.00 price target. To see the full list of analyst forecasts on medmix AG stock, see the CH:MEDX Stock Forecast page.
More about medmix AG
medmix is a global leader in high-precision delivery devices, serving healthcare, consumer, and industrial markets. The company is known for its innovation and technological advancement, holding over 900 active patents. With 14 production sites worldwide and nearly 2,700 employees, medmix is headquartered in Baar, Switzerland, and its shares are traded on the SIX Swiss Exchange.
Average Trading Volume: 61,468
Technical Sentiment Signal: Strong Sell
Current Market Cap: CHF361M
See more data about MEDX stock on TipRanks’ Stock Analysis page.